The Lancet
Cagrilintide for weight management in overweight or obesity
2021 · PMID 34481571
Lau DCW et al.
View sourceCompound information
Technical specifications for laboratory reference
Molecular profile
Research blend of cagrilintide (amylin analog) with a GLP-1/GIP/glucagon triple agonist (GLP-3 R) for combined metabolic-pathway studies in vitro.
Storage requirements
Lyophilized (powder)
−20°C · up to 24 months
Reconstituted
2–8°C · up to 14 days
Literature
Peer-reviewed research for laboratory background
The Lancet
2021 · PMID 34481571
Lau DCW et al.
View sourceThe New England Journal of Medicine
2023 · PMID 37366315
Jastreboff AM et al.
View sourceCitations are provided for research background only. Peptide Club materials are sold for laboratory research use — not for human or veterinary consumption. References do not constitute product claims.

Metabolic Compound
Research blend of cagrilintide (amylin analog) with a GLP-1/GIP/glucagon triple agonist (GLP-3 R) for combined metabolic-pathway studies in vitro.
Est. delivery Fri, Oct 2–Thu, Oct 8 · COA included · Same-day ship before 2PM PT
Apple Pay · Google Pay · Visa · Amex · Discover
Quality documentation
Third-party tested · batch-specific results
99.9%purity
Passed full QC panel
Batch COA PDF not linked yet for this variant. Email info@peptideclub.com or browse all COAs.